FIBROSIS: STATUS OF PHASE II AND III CLINICAL TRIALS FOR SKIN AND LUNG IN SYSTEMIC SCLEROSIS

被引：0
|
作者：
Denton, Christopher P. [1 ]
机构：
[1] UCL, Ctr Rheumatol, London, England
来源：
RHEUMATOLOGY | 2019年 / 58卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
I114
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Design issues in phase II/III clinical trials in mesothelioma
    Stephens, R.
    LUNG CANCER, 2006, 54 : S7 - S7
  • [32] Current phase II and phase III clinical trials in the treatment of colorectal cancer
    Mooney, MM
    Schoenfeldt, M
    ONCOLOGY-NEW YORK, 2004, 18 (11): : 1396 - +
  • [33] Review of Phase II and Phase III clinical trials for Duchenne muscular dystrophy
    Scully, Michele A.
    Pandya, Shree
    Moxley, Richard T.
    EXPERT OPINION ON ORPHAN DRUGS, 2013, 1 (01): : 33 - 46
  • [34] Performance status restriction in phase III cancer clinical trials.
    Kouzy, Ramez
    Jaoude, Joseph Abi
    Mainwaring, Walker
    Lin, Timothy
    Miller, Austin B.
    Jethanandani, Amit
    Espinoza, Andres F.
    Taniguchi, Cullen M.
    Ludmir, Ethan B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [35] High sensitivity CRP serves as a surrogate marker for severity of skin and lung fibrosis in systemic sclerosis
    Nevskaya, T.
    Novikov, A.
    Alexandrova, E.
    Guseva, N.
    Ananieva, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 218 - 218
  • [36] The protective effect of hydrogen sulfide on systemic sclerosis associated skin and lung fibrosis in mice model
    Wang, Zhi
    Yin, Xiaoya
    Gao, Luyan
    Feng, Sheng
    Song, Kai
    Li, Lingyun
    Lu, Ying
    Shen, Huaying
    SPRINGERPLUS, 2016, 5
  • [37] Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
    Sormani, Maria Pia
    Pardini, Matteo
    NEUROTHERAPEUTICS, 2017, 14 (04) : 924 - 933
  • [38] Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials
    Maria Pia Sormani
    Matteo Pardini
    Neurotherapeutics, 2017, 14 : 924 - 933
  • [39] Progression of Skin Fibrosis Is Associated with Decline in Lung Function in Patients with Diffuse Cutaneous Systemic Sclerosis: A European Scleroderma Trials and Research (EUSTAR) Analysis
    Wu, Wanlong
    Jordan, Suzana
    Graf, Nicole
    Pena, Janethe
    Curram, John
    Allanore, Yannick
    Matucci-Cerinic, Marco
    Pope, Janet E.
    Denton, Christopher
    Khanna, Dinesh
    Distler, Oliver
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [40] COMPARISON OF ANALYSIS APPROACHES FOR PHASE III CLINICAL TRIALS IN AMYOTROPHIC LATERAL SCLEROSIS
    Healy, Brian C.
    Schoenfeld, David
    MUSCLE & NERVE, 2012, 46 (04) : 506 - 511
12345